ArticleOphthalmology science2026
Intermediate Term Results of a Novel Minimally Invasive Keratoprosthesis.
Article in Ophthalmology science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Keratoprosthesis implantation remains a sight-restoring option in high-risk corneal transplantation where conventional keratoplasty is unlikely to succeed. Existing devices, such as the Boston keratoprosthesis (B-KPro), are very effective but long-term results are limited by glaucoma, infections, retroprosthetic membrane (RPM) formation, and retinal complications. We developed a minimally invasive keratoprosthesis (mi-KPro) that couples an ultrathin nitinol backplate with a poly(methyl methacrylate) optic and is implanted with a modified deep anterior lamellar keratoplasty (DALK) technique. Design: An experimental study in rabbits. Subjects: Thirty New Zealand white rabbits. Methods: Rabbits received severe alkali or acid corneal burns and 1-month later treated with mi-KPro or penetrating keratoplasty (PKP); an additional cohort underwent B-KPro implantation in naïve eyes. Animals were followed for up to 12 months with serial photography, intraocular pressure (IOP) measurements by intracameral manometry and TonoPen, and anterior and posterior segment OCT. Explanted eyes were histologically analyzed. Main Outcome Measures: Endpoints included device anatomic retention, RPM formation, infection, angle status, retinal thickness, and optic nerve axon density on histology. Results: The modified DALK approach allowed reproducible mi-KPro implantation with the nitinol backplate seated over Descemet membrane, and the optic extending into the anterior chamber through a 2.5-mm trephination. The mi-KPro eyes maintained clear optics without RPM, haze, or neovascularization and showed stable IOP (15.5 ± 2.2 at last follow-up vs. 15.6 ± 1.5 mmHg at baseline; Conclusions: The mi-KPro combines a minimally invasive surgical approach with a flexible nitinol backplate to achieve long-term retention, stable IOP, and preservation of posterior segment structure in severe chemical injury. These data support mi-KPro as a promising next-generation keratoprosthesis for high-risk corneal blindness. Financial Disclosures: Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.